StockData

Diodes vs Monolithic Power Systems

DIOD and MPWR side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DIOD and MPWR compare

Monolithic Power Systems is the larger company, worth 16 times as much as Diodes ($59.5B against $3.7B).

On earnings, Diodes is cheaper: it trades at 43.3× trailing earnings, against 74.0× for Monolithic Power Systems.

Monolithic Power Systems grew revenue faster over the last twelve months (28.7% versus 17.8% for Diodes).

Monolithic Power Systems keeps more of each dollar of sales as profit, with a net margin of 24.5% compared with 5.3% at Diodes.

Monolithic Power Systems pays a dividend yielding 0.62%; Diodes does not pay one.

Monolithic Power Systems scores higher on the StockData Score (18 against 10 for Diodes), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDIODMPWR
Size and price
Market cap$3.7B$59.5B
Share price$80.13$1211.63
Change, 1 year47.1%10.7%
Change, 5 years−25.5%122%
Beta (5Y)1.581.89
Employees7,9894,501
StockData Score
Total score1018 (better)
Valuation score1 (better)0
Growth score23 (better)
Performance score15 (better)
Health score66
Dividend score04 (better)
Valuation
P/E43.3× (better)74.0×
P/S2.3× (better)18.2×
P/B1.9× (better)15.3×
EV/EBITDA42.7× (better)58.1×
P/FCF25.9× (better)102×
PEG–5.96
FCF yield3.9% (better)0.98%
Fair value$51.28$695.14
Margin of safety−56.3% (better)−74.3%
Growth
Revenue growth (TTM)17.8%28.7% (better)
Revenue growth, 5Y average3.8%27.0% (better)
Net income growth (TTM)35.3% (better)−52.0%
EPS growth (TTM)35.0% (better)−52.5%
EPS growth, 5Y average−5.3%29.7% (better)
Profitability
Gross margin31.7%55.2% (better)
Operating margin4.8%28.7% (better)
Net margin5.3%24.5% (better)
FCF margin8.7%17.9% (better)
Return on equity4.5%22.6% (better)
Return on invested capital4.3%33.7% (better)
Financial health
Debt / equity0.00 (better)0.00
Net debt / EBITDA−5.63–
Interest coverage27.6×–
Current ratio3.174.98 (better)
Altman Z-score5.1147.90 (better)
Piotroski F-score7 (better)6
Dividends and buybacks
Dividend yield–0.62%
Payout ratio–41.1%
Years of dividend growth–8
Dividend growth, 5Y average–25.6%
Shareholder yield0.00%0.62% (better)
Ownership
Held by institutions99.5%96.9%
Held by insiders1.1%3.6%
Insider net buying, 12 months−$16.8M (better)−$728M
Superinvestors holding–1
Short interest, % of float5.6%3.9%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.